Atossa Therapeutics
ATOS
#9237
Rank
ยฃ77.44 M
Marketcap
ยฃ0.60
Share price
5.24%
Change (1 day)
-36.25%
Change (1 year)

Atossa Therapeutics (ATOS) Fails to deliver data

Key failure to deliver metrics for Atossa Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Atossa Therapeutics (ATOS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Atossa Therapeutics (ATOS) - since 2018

Volume in USD (price x number of shares), data since 2018

Atossa Therapeutics (ATOS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025ยฃ0.56 M-69.52%
2024ยฃ1.86 M265.91%
2023ยฃ0.5 M-93.57%
2022ยฃ7.92 M-92.88%
2021ยฃ0.11 B731.9%
2020ยฃ13.37 M-10.09%
2019ยฃ14.87 M138.47%
2018ยฃ6.23 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
ยฃ54.31 Mยฃ94.31 M๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
ยฃ14.74 Mยฃ33.36 M๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
ยฃ22.12 Mยฃ37.65 M๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
ยฃ0 Mยฃ0.33 M๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
ยฃ0.05 Mยฃ13.8 M๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
ยฃ0.77 Mยฃ3.68 M๐Ÿ‡บ๐Ÿ‡ธ USA